Replies to post #8338 on Repros Therapeutics, Inc. (RPRX)

[hiwatt1959]

This from their website under June talking points, page 12.
Expected Regulatory Path Forward for Proellex
®
¦ Repros empaneled a group of liver experts to review data and
provided opinion to the FDA in May 2017
¦ Reached agreement with division to accept additional information
from Repros, including opinion from company’s liver experts, for
submission to FDA internal liver panel
¦ Submit clinical protocol along with supplemental information
¦ FDA feedback may take 2-3 months